Immunostimulatory Effects of a Fermented <i>Moringa oleifera</i> Extract in Cyclophosphamide-induced Immunodeficient Mice

Background: Immunosuppression, characterised by impaired immune function, often results from chemotherapy, chronic infections, or autoimmune diseases, increasing susceptibility to infections and complicating disease management. Aim: This study evaluated the immunostimulatory effects of a fermented Moringa oleifera extract (MOE), with M. oleifera as the main constituent, combined with complementary herbs Celastrus hindsii and Curcuma longa, in cyclophosphamide (CY)-induced immunodeficient Swiss mice. Methods: Fifty mice were randomly assigned to five groups: normal control, model (CY-treated), positive control (thymomodulin), and MOE-treated (14.4 mL/kg/day or 28.8 mL/kg/day). Immunosuppression was induced via a single intraperitoneal CY injection (200 mg/kg) on day 4. Assessed parameters included body weight, relative spleen/thymus weights, total/differential leukocyte counts, delayed-type hypersensitivity (DTH) to ovalbumin (OA), serum IL-2, TNF-?, and IgG levels, and spleen/thymus histopathology. Results: MOE enhanced immune responses compared to the model group, showing a protective trend in DTH responses, cytokine levels (IL-2, TNF-?), and lymphoid organ histology. At 14.4 mL/kg, peripheral IL-2 rose significantly to 14.82 � 5.32 pg/mL (p 0.05) were found in organ weights, leukocyte counts, IgG levels, or DTH responses. Major Finding: These findings suggest that MOE exerts immunostimulatory effects, primarily by improving selected cytokines and histology endpoints, supporting its potential as a therapeutic agent for immunodeficiency.

View article page

Download PDF